• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

74.54 -0.60 (-0.80%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,653,520
Open 73.93
Bid (Size) 80.05 (200)
Ask (Size) 81.00 (100)
Prev. Close 75.14
Today's Range 73.24 - 74.87
52wk Range 54.11 - 89.98
Shares Outstanding 384,800,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
DexCom (DXCM) Q2 2026 Earnings Call Transcript ↗
July 30, 2026
Revenue hit $1.31 billion with strong international growth and margin expansion. 
Via The Motley Fool
Topics Earnings
News headline image
DexCom Q2 Earnings Call Highlights ↗
July 30, 2026
DexCom (NASDAQ:DXCM) reported second-quarter 2026 revenue growth of 13% from a year earlier, supported by continued demand for continuous glucose monitoring systems, expanding reimbursement access and... 
Via MarketBeat
Topics Earnings

Performance

YTD
+12.0%
+12.0%
1 Month
+10.7%
+10.7%
3 Month
+25.2%
+25.2%
6 Month
+0.7%
+0.7%
1 Year
-16.3%
-16.3%

More News

Read More
Which S&P500 stocks are moving after the closing bell on Thursday? ↗
July 30, 2026
Via Chartmill
Dexcom (NASDAQ:DXCM) Beats Q2 Earnings Estimates, Raises Profitability Guidance ↗
July 30, 2026
Via Chartmill
DEXCOM INC (NASDAQ:DXCM) Screens as a Strong Growth Stock with Favorable Technical Setup ↗
July 11, 2026
Via Chartmill
DexCom (NASDAQ:DXCM): An Affordable Growth Pick With Strong Momentum and Financial Health ↗
July 06, 2026
Via Chartmill
News headline image
DexCom’s (NASDAQ:DXCM) Q2 CY2026 Sales Beat Estimates
July 30, 2026
Via StockStory
Topics Earnings
News headline image
Dexcom Reports Second Quarter 2026 Financial Results
July 30, 2026
From DexCom, Inc.
Via Business Wire
News headline image
3 Beaten-Down Stocks With GLP-1 Exposure to Buy and Hold ↗
July 29, 2026
Via The Motley Fool
News headline image
DexCom Earnings: What To Look For From DXCM
July 28, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Kaskela Law Firm Announces Investigation of DexCom, Inc. (DXCM) and Encourages Long-Term DXCM Shareholders with Investment Losses to Contact the Firm
July 23, 2026
From Kaskela Law LLC
Via Business Wire
News headline image
Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program
July 22, 2026
From DexCom, Inc.
Via Business Wire
News headline image
Next-Generation Diabetes Therapies Are Reshaping Healthcare and Creating MultiBillion-Dollar Revenue Opportunities
July 21, 2026
Via FinancialNewsMedia
News headline image
2 Cash-Heavy Stocks on Our Buy List and 1 We Avoid
July 21, 2026
Via StockStory
Explore the top gainers and losers within the S&P500 index in today's session. ↗
July 16, 2026
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
July 16, 2026
Via Chartmill
News headline image
1 Mid-Cap Stock to Target This Week and 2 We Find Risky
July 14, 2026
Via StockStory
News headline image
Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time
July 09, 2026
From DexCom, Inc.
Via Business Wire
News headline image
Patient Monitoring Stocks Q1 Results: Benchmarking DexCom (NASDAQ:DXCM)
July 02, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
2 of Wall Street’s Favorite Stocks Worth Your Attention and 1 We Turn Down
July 02, 2026
Via StockStory
News headline image
3 Nasdaq 100 Stocks with Promising Prospects
July 01, 2026
Via StockStory
News headline image
Dexcom Further Advances Vision of Glucose Biosensing for All
June 23, 2026
From DexCom, Inc.
Via Business Wire
News headline image
Should You Buy Abbott Labs Stock Hand Over Fist Before July 16? ↗
June 20, 2026
Via The Motley Fool
News headline image
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend ↗
June 20, 2026
Via MarketBeat
Topics ETFs
News headline image
3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound ↗
June 18, 2026
Via MarketBeat

Frequently Asked Questions

Is DexCom, Inc. - Common Stock publicly traded?
Yes, DexCom, Inc. - Common Stock is publicly traded.
What exchange does DexCom, Inc. - Common Stock trade on?
DexCom, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for DexCom, Inc. - Common Stock?
The ticker symbol for DexCom, Inc. - Common Stock is DXCM on the Nasdaq Stock Market
What is the current price of DexCom, Inc. - Common Stock?
The current price of DexCom, Inc. - Common Stock is 74.54
When was DexCom, Inc. - Common Stock last traded?
The last trade of DexCom, Inc. - Common Stock was at 07/30/26 04:00 PM ET
What is the market capitalization of DexCom, Inc. - Common Stock?
The market capitalization of DexCom, Inc. - Common Stock is 28.68B
How many shares of DexCom, Inc. - Common Stock are outstanding?
DexCom, Inc. - Common Stock has 29B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap